MDK-7933

• CAT Number: I014461
• CAS Number: 1417997-93-3
• Molecular Formula: C22H19NO3
• Molecular Weight: 345.39
• Purity: ≥95%
• Synonyms: HDAC8-IN-1; MDK-7933; MDK 7933; MDK7933.;(E)-N-hydroxy-3-(5-methoxy-[1,1′:4′,1”-terphenyl]-2-yl)acrylamide
• Target: Epigenetics
• Solubility: Soluble in DMSO
• IUPAC Name: (E)-N-hydroxy-3-[4-methoxy-2-(4-phenylphenyl)phenyl]prop-2-enamide
• InChI: InChI=1S/C22H19NO3/c1-26-20-13-11-19(12-14-22(24)23-25)21(15-20)18-9-7-17(8-10-18)16-5-3-2-4-6-16/h2-15,25H,1H3,(H,23,24)/b14-12+
• InChIKey: ASHPRZYGCOMVHO-WYMLVPIESA-N
• SMILES: COC1=CC(=C(C=C1)/C=C/C(=O)NO)C2=CC=C(C=C2)C3=CC=CC=C3

MDK-7933（Cat No.:I014461）is an experimental small molecule under investigation for its potential therapeutic applications in cancer treatment. It acts by inhibiting specific proteins or signaling pathways involved in tumor growth, proliferation, and resistance to therapies. MDK-7933 is being studied for its ability to target cancer cells selectively, potentially enhancing the effectiveness of existing treatments such as chemotherapy or immunotherapy. As a novel compound, MDK-7933 is currently in preclinical or early clinical trials, with ongoing research to assess its safety, efficacy, and therapeutic potential for various types of cancer.